Ajay Piramal eyes $1 billion in contract pharma sale

Deliberations are at an early stage, and Piramal Enterprises could still decide against pursuing a deal, the people said.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2NLfjtk
via IFTTT